USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

Marketplace Community ScreenersActivity LandscapeEfficient FrontierCorrelationsRisk/Return

US Market Closed: Mar 15, 19:39 PM 2010

NYSE 7350.96 11.89 Index Moved Down

NASDAQ 2362.21 5.45 Index Moved Down

Search is sponsered by

Outlook Integration

Processing
Collecting necessary data for SLXP...

Salix Pharmaceuticals Ltd. discussions, twits, chats, blogs, and headlines

SLXP	Stock NasdaqNM

Salix Pharmaceuticals Ltd.

{Name}

{Date}

{Time}

{Text}

{Label:Like this comment?} [{Label:yes}] [{Label:no}] ({Label:Score}: 0{Label:byVotes} 0)

{Label:Mark as} [{Label:offensive}]

{Label:leaveComment}

{Label:nameLabel}

{Label:emailLabel}

{Label:emailNote}

{Label:ratingLabel}

{Label:commentLabel}

Salix Pharmaceuticals, Ltd. (SLXP) ? Contrarian bullish options trading initiated on the specialty pharmaceuticals firm indicates one inv...

2010-03-03

Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) closed at $24.25 and shares are up 18% at $28.65 on 200893 shares as of 8:26 AM EST. The company reported that the FDA Advisory Committee recommended approval Of XIFAXAN� (rifaximin) tablets ...

2010-02-24

Salix Pharma (NASDAQ: SLXP) is hitting the list today as investors prepare their portfolios ahead of tomorrow's FDA panel discussion surrounding Salix's Xifaxan drug for the treatment of liver dysfunction. Earnings, while not confirmed, ...

2010-02-22

Salix Beats but Outlook Disappoints (Zacks.com)

2010-03-15

The current Zacks Consensus Estimate for the fourth quarter of 2009 is a loss of 14 cents. For the full year, the Zacks Consensus Estimate stands at a loss of 89 cents.

2010-03-15

Good News for Salix (Zacks.com)

2010-03-15

163 Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) 99.8% 164 Technology Research Corporation (NASDAQ:TRCI) 99.8% 165 K12 Inc. (NYSE:LRN) 99.8% 166 Willis Group Holdings PLC (NYSE:WSH) 99.8% 167 Nationwide Health Properties Inc. (NYSE:NHP) 99.8% .... 326 Vanguard Total Stock Market ETF (NYSE:VTI) 99.5% 327 iShares Dow Jones Transport. Avg. (ETF) (NYSE:IYT) 99.5% 328 The Valspar Corporation (NYSE:VAL) 99.5% 329 The Home Depot, Inc. (NYSE:HD) 99.5% ...

2010-03-15

2010-03-11

173 United Online, Inc. (NASDAQ:UNTD) 46.1% 174 Spartech Corporation (NYSE:SEH) 46.1% 175 Maxwell Technologies Inc. (NASDAQ:MXWL) 46.0% 176 Virtual Radiologic Corporation (NASDAQ:VRAD) 45.9% 177 Cal Dive International, Inc. (NYSE:DVR) 45.8% .... 361 Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) 29.9% 362 Cynosure, Inc. (NASDAQ:CYNO) 29.8% 363 RailAmerica, Inc. (NYSE:RA) 29.6% 364 Openwave Systems Inc. (NASDAQ:OPWV) 29.6% 365 Fresh Del Monte Produce Inc. (NYSE:FDP) 29.6% ...

2010-03-14

SLXP Salix Pharmaceuticals Ltd. SMCI Super Micro Computer, Inc SNDK SanDisk Corp. SNHY Sun Hydraulics Corp. SNWL SonicWALL, Inc. SPRT Support.com, Inc. SRGG Surge Global Energy, Inc. STRL Sterling Construction Co. Inc. ... UNG - United States Natural DNR - DENBURY RESOURCES INC QCOM - QUALCOMM Incorporated SOLR - GT Solar International HD - HOME DEPOT INC HIG - Hartford Financial UNH - UNITEDHEALTH GROUP INC TSO - Tesoro Corp V - VISA Inc EWH - WEBS Hong Kong ...

2010-03-11

Salix Pharmaceuticals, Ltd. (SLXP) recently held a pre-NDA meeting with the US Food and Drug Administration (FDA) related to the company's new drug. ... IBS is one of the most common chronic conditions and affects about 15% of adults in the United States. According to the company, the non-constipation IBS market could represent commercial opportunity in the range of approximately $7 billion. Salix intends to file the NDA for the non-C IBS indication in the first half of ...

2009-12-16

On Macroaxis Blog

	MYR Group posts 44 pct drop in 4Q net income (AP)
	UPDATE - Sequenom posts wider-than-expected Q4 loss (at Reuters)
	Cadence Pharmaceuticals reports 4Q loss (AP)
	GTx reports smaller 4Q loss as product sales rise (AP)
	Movado to post 4Q loss, industry woes continue (AP)
	ParkerVision 4Q loss narrows on revenue (AP)
	Orascom Telecom posts $46 million Q4 net loss (AP)
	Microchip Technology raises fiscal 4Q outlook (AP)
	AthenaHealth posts drop in 4th-quarter profit (AP)
	UPDATE - BancorpSouth revises Q4 results (at Reuters)

Subscribe To Feed

30-Day Moving Performance

Macroaxis Total Score

Current 30 Days Moving Rating

Current Net Investing Interest

Estimated Market Risk

5.48

actual daily

24 %

of total potential

Expected Return

0.79

actual daily

33 %

of total potential

Risk-Adjusted Return

0.14

actual daily

7 %

of total potential

Based on monthly moving average [ change ]

Increase Risk-Adjusted return of SLXP by adding it to a well-diversified portfolio

Diversify

Partner Center

Compare To

Perrigo NBTY Herbalife Auxilium USANA Prestige CHBT China Schiff BJGP Tiens NUTR Mannatech Natural Medical Cyanotech

Risk & Return

Correlation

Follow Salix using RSS feed

Add this feed to your online news reader